围术期静脉克林霉素可能提高Roux-en-Y胃旁路术后高血压缓解率
该回顾性分析纳入2012至2016年行Roux-en-Y胃旁路术(RYGB)或袖状胃切除术(SG)的成人减重患者,比较围术期预防性使用头孢唑林与克林霉素(青霉素过敏者)对高血压缓解率的影响。结果显示,在RYGB患者中,克林霉素组高血压缓解率显著高于头孢唑林组,该效应从术后2周持续至1年;而在SG患者中未观察到显著差异。
要点
- RYGB术后高血压缓解率克林霉素组高于头孢唑林组,2周时52.4% vs. 23.5%(p=0.008)。
- 该差异持续至1年,57.9% vs. 44.0%(p=0.05)。
- SG患者中两种抗生素的高血压缓解率无显著差异。
核心结论
- 围术期静脉预防性使用克林霉素与RYGB术后高血压缓解率显著升高相关,而SG患者中未观察到此现象。
研究设计与样本
- 回顾性分析2012至2016年接受RYGB或SG的成人减重患者,共纳入123例RYGB和88例SG。
主要发现
- RYGB患者中,克林霉素组术后2周高血压缓解率为52.4%,头孢唑林组为23.5%(p=0.008)。
- RYGB患者中,克林霉素组术后1年高血压缓解率为57.9%,头孢唑林组为44.0%(p=0.05)。
- SG患者中,头孢唑林与克林霉素的高血压缓解率无显著差异。
关键数值与推荐
- 高血压缓解标准为随访时不再需要药物治疗。
- 随访时间点为术后2周(±1周)、6周(±2周)、3个月(±2周)、6个月(±6周)和1年(±2个月)。
临床怎么用
- 对于接受RYGB的青霉素过敏患者,围术期选用克林霉素可能有助于提高术后高血压缓解率,但需未来研究确认机制。
局限性
- 本研究为回顾性分析,样本量有限,且克林霉素仅用于青霉素过敏患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent studies have suggested that potential aberrant alterations in the gastrointestinal microbiome contribute to the development of cardiovascular disease, specifically hypertension. Bariatric surgery produces significant sustained weight loss and hypertension resolution likely through multiple mechanisms which includes beneficial changes in the gut microbiome. We hypothesized that the type of prophylactic antibiotic given for bariatric surgery could impact the resolution rate of hypertension by altering the post-operative gastrointestinal microflora. METHODS: A retrospective analysis of adult bariatric patients who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) between 2012 and 2016 was conducted. The standard antibiotic prophylaxis was cefazolin, or clindamycin in patients with a penicillin allergy. Univariate analyses were performed comparing the differing peri-operative antibiotic treatments with resolution of hypertension at 2-week (± 1 week), 6-week (± 2 weeks), 3-month (± 2 weeks), 6-month (± 6 weeks), and 1-year (± 2 months) follow-up appointments. The criterion for resolution of hypertension was no longer requiring medication at time of follow-up. RESULTS: In total, 123 RYGB and 88 SG patients were included. No significant differences were found between cefazolin and clindamycin regarding hypertension resolution rates after SG. However, patients who underwent RYGB and received clindamycin had a significantly higher rate of hypertension resolution compared to cefazolin. This effect started at 2 weeks post-operatively (52.4% vs. 23.5% respectively, p = 0.008) and persisted up to the 1-year (57.9% vs. 44.0% respectively, p = 0.05). CONCLUSION: Prophylactic peri-operative, intravenous clindamycin was associated with significantly increased resolution of post-operative hypertension compared to cefazolin. This finding was not observed in SG patients. Future studies are needed to confirm the mechanism of action for this novel finding is due to the differing modifications of the gastrointestinal microflora after RYGB resulting from the specific peri-operative antibiotic administered.
引用
- Patz JJ, Helm MC, Higgins RM, et al. Peri-operative, intravenous clindamycin may improve the resolution rate of hypertension after Roux-en-Y gastric bypass in morbidly obese patients. Surg Endosc. 2019. PMID: 30734082. doi:10.1007/s00464-019-06687-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。